March 19, 2021 (LifeSiteNews) — The European Medicines Agency, Europe’s drug regulator, concluded on Thursday afternoon that the Oxford/AstraZeneca COVID-19 vaccine is safe to use. Previously, it had been suspended in more than a dozen European countries where concerns were growing because of blood clot incidents. Vaccinations will resume in most countries, but the Scandinavian countries — Norway, Sweden, and Denmark — will wait.
The pause may well have been triggered by recent findings by a Norwegian research team that thinks it has found the reason for the thrombosis following the AstraZeneca shot.
The team decided to investigate the reason why three health workers — all under 50 years old — experienced severe thrombosis shortly after having received the jab. One of them died last Monday from brain haemorrhage.
Their results were made public on Thursday, but did not change the EMA’s approach: The European drug regulator merely decided to add a warning that it could not definitively rule out a link between the AstraZeneca jab and a “blood clotting disorder.” Despite several incidents and three deaths due to thrombosis following vaccination, EMA’s executive director Emer Cooke proclaimed: “I want to reiterate that our scientific position is this: This vaccine is a
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors